Work

The Ethical Case for Decentralized Clinical Trials

Year: 2024

Type: article

Abstract: The recent pandemic spurred interest in innovative design for clinical trials. In particular, constraints on the public's ability to gather led to an increase in remote or decentralized clinical trials (DCTs). DCTs present an opportunity to extend the benefits of research to underserved populations, decrease burdens, increase access to trials, and fill knowledge gaps surrounding rare conditions, though they are not without their own unique challenges and risks. These risks are far from irremediable, and the advantages are significant enough to merit attention. There is a scientific and moral case to increase the use of DCTs beyond the context of public health emergencies.

Source: Ethics & Human Research

DOI: 10.1002/eahr.500229

Authors: Kathryn Muyskens, Ivan Z. Y. Teo, Jerry Menikoff, G. Owen Schaefer

Institution: National University of Singapore

Language: English

Topic: Ethics in Clinical Research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Medical Research Council, National Medical Research Council